FDA re-opens probe into benzene contamination of soft drinks

2/15/2006- US food safety authorities have re-opened an investigation closed 15 years ago into soft drinks contaminated with cancer-causing chemical benzene, following evidence the industry has failed to sort out the problem.

A chemist at the Food And Drug Administration (FDA) said testing in recent weeks had revealed some soft drinks contaminated with benzene at levels above the legal limit for water set by the US and Europe.

Benzene is listed as a poisonous chemical shown to increase the risk of leukaemia and other cancers.

The FDA was originally alerted in 1990 to the problem of benzene in soft drinks triggered by the preservative sodium benzoate. It never made the findings public, but came to an arrangement with the US soft drinks association that the industry would “get the word out”.

But in recent months, internal documents and private tests have begun to surface, supported by claims from a former chemist for Cadbury Schweppes, who is now keen to blow the whistle on the health risk involved. He and a US lawyer commissioned new tests that have now prompted the FDA to re-open the case.

These independent tests, performed by a laboratory in New York, found benzene levels in a couple of soft drinks two-and-a-half-times and five times above the World Health Organisation limit for drinking water (10 parts per billion).

The FDA now confirms it has found a similar problem in its own follow-up testing. “There were a few isolated products that have elevated levels. We certainly want to make sure there is some reformulation,” said an FDA chemist.

The problem is caused by two common ingredients – sodium benzoate and ascorbic acid (vitamin C) – which can react together to cause benzene formation. It is considered completely separate from other outbreaks of benzene contamination due to faulty packaging in the 1990s.

Virus Found in Prostate Cancer Patients
By PAUL ELIAS
The Associated Press
Friday, February 24, 2006; 10:21 PM

SAN FRANCISCO — Researchers said Friday they have found a virus in the prostates of some cancer patients, a remarkable discovery that may suggest disease could play a role alongside genetics and the environment in causing this cancer.

The virus, closely related to one previously found only in mice, was found in cancerous prostates removed from men with a certain genetic defect. The findings open new avenues for studying the most common major cancer among men in the United States.

The researchers, with the University of California, San Francisco, and the Cleveland Clinic, presented the findings at an American Society of Clinical Oncology meeting in San Francisco. They warn that they have not found any links between the virus and prostate cancer, but they are nonetheless excited about prospects for future research.

“We have made a very fascinating discovery never before seen in humans that is very similar to one found in a mammal that causes cancer,” Dr. Eric Klein of the Cleveland Clinic said at a news conference. “But we have not proven this virus causes prostate cancer.”

Infectious disease-causing viruses are already blamed for some liver cancers and cervical cancer. That has planted nagging suspicions in the minds of scientists that some diseases may play important roles alongside genetics, environment and chance in causing breast, stomach and several other forms of cancer.

Researchers are not sure how the mouse virus infected people, but suspect it has been passed on genetically for many generations.

“This is a class of virus no one would have looked for in prostate cancer,” said UCSF researcher Joe DeRisi, who developed the so-called “gene chip” that made the discovery. DeRisi’s chip contains 20,000 snippets of vital genetic material from every known virus. It is the same chip that confirmed a previously undiscovered virus in the cold family that caused the SARS outbreak three years ago.

Klein sent samples of 86 cancerous prostates he removed from patients to DeRisi. DeRisi then placed DNA from the cancerous tissues on the chip, and DNA from eight of 20 patients with two copies of a mutated gene matched with DNA from the mouse virus.

The gene is a vital cog in the body’s defense system, coding for an enzyme that helps kill invading viruses. The men with the mutated genes make fewer such enzymes than those with normal versions of the gene.

The virus was found in just one of the 66 other patients, suggesting that genetics play a significant role in the virus’ connection to cancer.

TEFLON BYPRODUCT POLLUTING THE MISSISSIPPI RIVER
A government scientist has been forced to resign, after discovering dangerous levels of a toxic chemical in the Mississippi River. The toxins, specifically known as perfluoronated chemicals (PFCs), are a byproduct of the manufacture of a number of products including Teflon and Scotchgard. In late 2005, Dr. Oliaei Fardin found dangerous levels of PFC’s in the Mississippi River downstream from a 3M Corporation’s dumping site in Minnesota. 3M had been dumping 50,000 pounds of the toxic chemical in the river every year, in a heavily populated metropolitan area, where the river serves as the main drinking water source for Minneapolis and St. Paul. PFCs have caused birth defects and deaths in animal studies and are considered a likely human carcinogen. Fardin, a scientist at the Minnesota Pollution Control Agency, found levels of PFCs in the area’s fish that were the highest ever discovered in the world. Following her discovery, she was unable to get the state to issue a public health advisory, as would normally be required by law. After she filed a federal whistleblower’s lawsuit against the agency, Fardin was forced to resign by the Minnesota Pollution Control Agency’s Commissioner, a former Executive of 3M. Her research, which has now been halted, would have helped assess how far downstream the chemical contamination had traveled in the Mississippi River, one of the nation’s largest waterways and municipal water sources.

There is a lot of discussion going on about the benefits of square waves vs. sine waves for frequency applications. For generation of maximum effect on pathogens when you have the correct frequencies, square waves work best. For direct application of electrodes, positive offset square waves should be used. This will shorten the time needed to eliminate pathogens because (1) square waves are more disruptive to the pathogen and (2) square wave harmonics aid in eliminating them. This is true for primary frequencies and scalar octaves.

Wikipedia has an excellent discussion of square waves.

Square wave

A square wave is a basic kind of non-sinusoidal waveform encountered in electronics and signal processing. An ideal square wave alternates regularly and instantaneously between two levels, which may or may not include zero.

Origins and uses

Square waves are universally encountered in digital switching circuits and are naturally generated by binary (two-level) logic devices. They are used as timing references or “clock signals“, because their fast transitions are suitable for triggering synchronous logic circuits at precisely determined intervals. However, as the frequency-domain graph above shows, square waves contain a wide range of harmonics; these can generate electromagnetic radiation or pulses of current that interfere with other nearby circuits, causing noise or errors. To avoid this problem in very sensitive circuits such as precision analogue to digital converters, sine waves are used instead of square waves as timing references.

In musical terms, they are often described as sounding hollow, and are therefore used as the basis for wind instrument sounds created using subtractive synthesis.

An important area of research to be discussed at the Las Vegas workshop is nutritional strategies for use in combination with Rife frequencies to target malignant cells. Immune enhancing supplements, in combination with frequency applications, helps deliver a one-two punch to malignant cells.

For immune enhancement I use Transfer Factor Plus Advanced Formula exclusively on a daily basis. Occassionally, those with auto-immune diseases do better on regular Transfer Factor. I have seen Transfer Factor alone enable the immune system to kill basal cell carcinomas.

Searching on www.pubmed.org for zeolite and cancer will give you 104 new medical journal papers to add to your reading list. Zeolite has been packaged into a patented nutritional supplement called Natural Cellular Defense. There are others coming onto the market.For cancer or suspected cancer (like a high PSA level), I add Zeolite to the supplement program to give an additional boost to the immune system, assuming muscle testing for the supplement is positive.

Patent applications and even patent submissions are in the public domain and easily accessible from the U.S. Patent Site from the link below. The government grants patent rights to inventors only if they put the patent into the public domain so others can see exactly what the patent is, how it works, and what it applies to. This patent has been assigned by the inventor to Lifelink Pharmaceuticals who owns all rights to it. It is not clear whether rights have been further assigned to others.

United States Patent 6,288,045
Kaufman September 11, 2001
Epithelial cell cancer drug

Abstract

A method of treating epithelial cell cancer comprising administering to a mammalian patient diagnosed as having an epithelial cell cancer a therapeutically effective amount of 4,5 di-cyclo, disilico, dimagnesium, dialumino, oxyo, trihydrate, or its acetate, sulfate, hydrochlorate, or brominate salts. The composition is synthesized from a naturally occurring non-toxic zeolites, and has a 100% kill rate within 72 hours against buccal mucosa and ling squamous epithelial cell cancers. It is not cytoxic to healthy human cells.

Inventors: Kaufman; Harvey (Hudson, OH)
Assignee: Lifelink Pharmaceuticals, Inc. (Stow, OH)
Appl. No.: 591701
Filed: June 9, 2000

BACKGROUND OF THE INVENTION

The present invention is directed to a new and unique anticancer drug, which is identified generically as 4,5 di-cyclo, disilico, dimagnesium, dialumino, oxyo, trihydrate (3Mg++.3Al.sub.2 O.sub.3.3SiO.sub.2.3H.sub.2 O), which is a magnesium aluminosilicate (referred to hereinafter as “MAS”), and which are in the acetate, sulfate, chloride, or brominate form. These compositions come from a class of inorganic aluminosilicate chemicals known as zeolites. The compounds of the present invention are particularly useful in treating epithelial cell cancers in mammals.

The involvement of cancerous epithelial cells, which lead to the formation of solid tumors in humans, in such organs as the lungs, breast, skin, mouth, and colon are known as carcinomas. Most of the epithelial cell cancers are treated using chemotherapeutic agents and these tend to be toxic, and have immunosuppressive side effects. When treated this way, the cancer patient must then wait up to 3 weeks for his next treatment, until his immune system has restored itself.

Cancers involving human epithelial cells come from solid tumors of the breast, lung, stomach, liver, uterus, colon, skin, mouth and uterine cervix can form. Adenocarcinomas from secretory tissue and squamous carcinomas from protective linings are the two basic categories of carcinomas. Epithelial cell based cancers proliferate rapidly respecting no cellular boundaries. To fully understand how to treat epithelial cell based cancer, one must start at the cellular level, this involving use of cell culturing techniques. Present day drugs used for chemotherapy do not directly attack the cancer cell with any great accuracy. Drugs such as Methotrexate and Vincristine are toxic to normal healthy cells and diminish immune system functions. These usually offer the cancer patient extremely disquieting side effects such as diarrhea, hair loss, vomiting and weakness. The toxicity of these drugs often shorten their use or require a very intermittent use. The average chemotherapy cannot be used more than once a month.

A large effort has been put forth by the medical research community to find new drugs for the treatment of epithelial cell based cancers. Carcinoma of the lung, breast, prostate, and colon all together account for more than half of the deaths from cancer in North America. Anticancer drugs have for the most part been categorized into alkylating agents such as cytoxan, antitumor antibiotics such as dactinomycin and antimetablite drugs such as methotrexate. Most, if not all, of these chemotherapies have major side effects and are toxic.

It is well known that chemicals cause 95% of all cancers contracted by humans. Some of the most potent carcinogens are aldehydes, ketones, pyrenes, benzpyrenes, benzene, and nitrosamines. Nitrosamines were looked at early on because they are carcinogenic agents found in cigarette smoke and in the causative agents of rubber polymers.

Zeolites are natural hydrated silicates of aluminum and, usually, either sodium or calcium or both. Zeolites such as sodium aluminosilicate have a unique multi-dimensional structure of cavities into which small to medium size molecules and cells can be trapped. They exist in natural and artificial forms and are used extensively for water softening, as detergent builders, and cracking catalysts. Natural zeolites include analcite, chabuzite, heulandite, natrolite, stilbite, and thomosonite.

Zeolites have been used in animal feed. For example, as reported in “World Food & Drink Report”, Apr. 19, 1990, hydrated sodium calcium aluminosilicate, an anti-caking agent used in animal feed, may reduce levels of aflatoxin in the milk of animals eating contaminated grain. Further, German patent DE19755921 teaches the use of zeolites or klinopitolites, that are used as food additives for human consumption as an aid to health, after they are treated with tribomechanical action to increase their surface area and destabilize their structure to release their chemical potential. These materials are thought to be a useful defense against cancers such as lung cancer, cancer of the colon, and skin cancer, and they are recommended for improving blood circulation.

SUMMARY OF THE INVENTION

The present invention has resulted from the discovery that epithelial cell cancer can be treated by administering to a mammalian patient having an epithelial cell cancer a therapeutically effective amount of 4,5 di-cyclo, disilico, dimagnesium, dialumino, oxyo, trihydrate acetate, sulfate, hydrochlorate, or bromate. The composition of the present invention is synthesized from a naturally occurring non-toxic zeolites, and has a 100% kill rate within 72 hours against buccal mucosa and ling squamous epithelial cell cancers. It is not cytoxic to healthy human cells.

Frequencies on this site are always expressed in the F165 scripting language as F165 programs are precise and can be easily converted for devices that lack automated capabilities. A common conversion is from an F165 program to frequencies for the FSCAN.

#F165 Sample Program
repeat 5
dwell 720
program c
vbackfreq a 0.002478752 0 66.6
vbackfreq b 0.049787068 0 66.6
converge 0 0
12677.6 # protein
converge .17% .1
1662 2774
248666
end repeat

The repeat 5 command causes the program to cycle 5 times.

The dwell is time in seconds so 720 seconds means run for 12 minutes. It you repeated 5 times the total would be 60 minutes.

The FSCAN does not support multiple channels so ignore the scalar waves generated by vbackfreq commands.

The converge function is roughly equivalent to wobble for the FSCAN and converge 0 0 means wobble 0.

The converge .17% .1 command means wobble at .17% of the frequency at an
interval of .1hz. The FSCAN only wobbles with an interval of 1hz so
ignore the .1hz.

Multiply 1662 by .17% = 2.8hz for wobble.

Multiply 2774 by .17% = 4.7hz for wobble.

Multiply 248666 by .17% = 422.7hz for wobble.

At the Las Vegas Workshop 17-19 Feb 2006, new research findings will be discussed. One item on the agenda is using frequencies to mimic the action of a drug as noted in the Jacques Beneviste patent posted previously.

Christopher Bird reviewed Rife’s work and was sent to investigate Gaston Naessens who constructed a microscope with resolution similar to Rife’s. Naessens viewed the lifecycle of somatids, subcellular organisms that he thought were the basis of all life. Chronically ill patients always had abnormal somatid pleomorphic forms in their blood. He developed 714-X, a drug injected into a lymph node in the groin that normalized the somatid life cycle by enhancing the immune system.

With this approach he restored 750 out of 1000 cancer patients to health leading to his persecution and trial in Canada, a trial which he won. Christopher Bird provides a compelling narrative of trial proceedings in The Persecution and Trial of Gaston Naessens.

What if there was a frequency program that could be used to plate zap lymph nodes that generated the same effect. This is an interesting topic of research which will be discussed at the Las Vegas Frequency Research Workshop.

Safety of artificial sweetener called into question by MP

Examples cited in the Commons of the 6,000 products with aspartame

Felicity Lawrence, consumer affairs correspondent
Thursday December 15, 2005
The Guardian

In 1977 Donald Rumsfeld, now George Bush’s defence secretary but then chief executive of the pharmaceutical company GD Searle, publicly stated that he would “call in his markers” to win a licence for aspartame, the sweetener that had been discovered by chance in Searle’s laboratories, according to Roger Williams in the Commons yesterday.

Mr Williams, MP for Brecon and Radnorshire, said in an adjournment debate that there was much controversy about aspartame’s safety at the time but “Rumsfeld appears to have honoured his pledge”. In fact, “the history of the approval of aspartame puts public health regulators and politicians to shame”.

The sweetener is now used in 6,000 products, from crisps such as Walkers prawn cocktail, to soft drinks including Diet Coke and Robinson’s fruit squash, chewing gums such as Orbit, and vitamins pills and medicines. Yet the science on which it was given approval was “biased, inconclusive, and incompetent”. “There is compelling and reliable evidence for this carcinogenic substance to be banned from the UK food and drinks market.”

On the day of his inauguration as president in 1981, with Mr Rumsfeld on his transition team, Ronald Reagan personally wrote an executive order suspending the head of the US Food and Drug Administration’s powers on aspartame, Mr Williams further claimed. One month later Mr Reagan appointed a new head of the regulatory authority, Arthur Hayes, who granted a licence for the sweetener.

“The history of aspartame’s approval is littered with examples showing that if key decision makers found against aspartame’s safety, they were discredited or replaced by industry sympathisers, who were recompensed with lucrative jobs.”

The MP said he was using his parliamentary privilege to highlight “the strong scientific evidence” that the components of aspartame and their metabolites can cause very serious toxic effects on humans, and that long-term aspartame use can cause cancer.

U.S. Patent 6,541,978, April 1, 2003
Method, system and device for producing signals from a substance biological and/or chemical activity
Benveniste; Jacques (Paris, FR); Guillonnet; Didier (Cagnes-sur-mer, FR)

The present invention relates to a method, a system and a device for producing signals from a substance, in particular electric signals, characteristic of the biological and/or chemical activity or the biological and/or chemical behaviour of said substance or an active element contained in said substance. The invention also relates to a method and a system for controlling said signals. The invention also relates to the applications of said method, system and device in particular to the production of active substances and to the detection of defined substances. Finally, the invention relates to signals linked to a biological and/or chemical activity thus produced by said method, system and device.

It is known from the research works of Jacques Benveniste, in particular those described in the patent application WO 94/17406 published on Aug. 4, 1994, that one can pick up, from a biological and/or chemical active element such as a chemical compound, a cell or a micro-organism, or from a substance containing this active element such as a purified preparation, a biological sample, or a living being, an “electromagnetic signal characteristic of the biological and/or chemical activity or of the biological and/or chemical behaviour” of said substance and/or said active element contained in said substance.

It is also known that it is possible to transform, in particular by means of a transducer, such an electromagnetic signal into electric signals. In the following text one also means by “electric signals characteristic of the biological and/or chemical activity or of the biological and/or chemical behaviour of said substance or of an active element contained in said substance” the electric signals derived by signal digitising and/or processing. In this expression the word “characteristic” is used in the meaning where the physical parameters of the electric signals are specific to the substance or to the active element contained in said substance and that the application of these electric signals, via a transducer, to a biological control system makes it possible:

(i) to induce a biological and/or chemical activity on said biological control system relative to that of the substance of origin or the active element it contains;

(ii) to reveal a characteristic of the substance or the active element it contains, at the origin of said electric signals.

The patent application WO 94/17406 published on Aug. 4, 1994, describes a method and a device for picking up “an electromagnetic signal characteristic of a biological and/or chemical activity or of a biological and/or chemical behaviour” from a biological and/or chemical active element such as a chemical compound, a cell or micro-organism, or from a substance containing this active element such as a purified preparation, a biological sample, or a living being.

Since then the inventors have discovered that it is possible to improve the quality of the electromagnetic signal picked up as well as the reliability of the method for producing these signals and that consequently it is possible to produce characteristic electric signals appropriate for industrial applications. The production of such characteristic electric signals implies an exceptional industrial importance.

It thus becomes possible to detect and characterise active elements present in low concentration or in very low concentration in a substance. As examples, it is thus possible to monitor the presence or absence of chemical compounds such as caffeine, ionophoretic-calcium, ovalbumin, propranolol or micro-organisms such as bacterium coli, streptococci, staphilocci whose presence is looked for.

It thus becomes possible to carry out remote tests at several thousands of kilometers since the characteristic signals are electric signals which can immediately be transmitted to the investigation centre of the control laboratory.

It is possible to modify the biological and/or chemical activity or the biological and/or chemical behaviour of a biological receptor system by submitting it to the effects of characteristic electric signals. It also becomes possible to produce new drugs such as solutions depending on signals from arnica, bradykinin, caffeine, nicotine. New production techniques for drugs can be implemented. For example, in the case of certain drugs such as antibiotics, anti-viruses, anti-parasites, anti-mitotics which, to act within bacteria, viruses or cells (tumour cells in particular), must breach the defensive barriers of the above, the signals of these drugs are applied directly into the heart of the bacteria, viruses or cells. In fact, the application of characteristic electric signals, via an appropriate transducer, generates magnetic fields which penetrate into the bacteria, viruses or cells and modify their chemical and/or biological behaviour.

It is possible to store the characteristic electric signals in data banks, using computer techniques. Then, the spread of therapeutic resources, from one point to the other on the planet, is instantaneous according to needs.